Podcasts

The short-sightedness of clinical trials

The short-sightedness of clinical trials

The results of randomized clinical trials to test nutrients continues to grab the headlines, and more often than not the titles are not positive. Is the emphasis on a trial model anchored in drug testing a good thing for nutrition? Stephen Daniells talked...

Omega-3 and the search for alternative sources

Omega-3 and the search for alternative sources

Omega-3 fatty acids are one of the industry's star performers, being added to a wide variety of food types as well as supplement capsules. But searching for alternative sources continues behind the scenes. Stephen Daniells talks to Prof Ski Chilton...

Three parties, one project: the probiotic straw

Three parties, one project: the probiotic straw

A drinking straw innovator, a leading probiotics supplier and the world’s biggest aseptic beverage packager have teamed up to deliver a probiotic drink that has attracted the interest of the world’s biggest beverage companies. Shane Starling met with...

Petitions: The new tool to attack supplements

Petitions: The new tool to attack supplements

The petition filed earlier this year by GSK in an effort to wipe out the dietary supplement category for weight loss is unlikely to pass. But it highlights a major new threat to the industry: The use of petitions to discredit the supplements sector. Lorraine...

The pros and cons of antioxidant claims

The pros and cons of antioxidant claims

Stephen Daniells canvases views on the use of the term 'antioxidant' and whether the industry is storing up future problems by over-egging their potential.

HIE round-up: quality, not quantity

Dispatches from Health Ingredients Europe

HIE round-up: quality, not quantity

As the stands came down on day three in Paris, NutraIngredients.com canvassed industry opinion about Europe's marquee healthy nutrients event, Health Ingredients Europe. Had it been affected by the financial crisis and impact of new EU regulations?

The biggest challenges in making GMPs work

The biggest challenges in making GMPs work

Many medium and small dietary supplement companies are still not close to meeting new GMP requirements, despite the looming deadlines. Lorraine Heller speaks to industry members about the major challenges that remain, and the next steps that should be...

Exploring the sweet future for stevia

Exploring the sweet future for stevia

As regulatory approval for stevia and its extracts gathers pace in the US, Mark Blumenthal from the American Botanical Council gives his thoughts and inside knowledge on his nominee for ‘herb of the year’.

What is Section 912?

What is Section 912?

Stuart Craig, Danisco's director of Regulatory and Scientific Affairs, North America, explains why Section 912 could have a major impact on the way dietary supplements are regulated in the United States.

What NutraIngredients-USA took away from SSW

What NutraIngredients-USA took away from SSW

The curtains have closed on SupplySide West 2008. Our reporters Stephen Daniells and Lorraine Heller share their thoughts on the major take-aways from the ingredients, science and education on offer at the biggest annual event for the North American nutraceutical...

The coffee and energy drink caffeine divide

The coffee and energy drink caffeine divide

Coffee and tea-based products are free from the caffeine labelling requirements of energy drinks. But is this in consumers’ best interests? Neil Merrett reports.

Follow us

Products

View more

Webinars